Laudexium metilsulfate

From Wikipedia, the free encyclopedia
  (Redirected from Laudexium)
Jump to navigation Jump to search
Laudexium metilsulfate
Laudexium metilsulfate.svg
Clinical data
Synonyms Laudolissin
Routes of
administration
IV
Legal status
Legal status
  • discontinued from clinical use
Pharmacokinetic data
Bioavailability 100% (IV)
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
Chemical and physical data
Formula C54H80N2O16S2
Molar mass 1077.35 g/mol
3D model (JSmol)
 ☒N☑Y (what is this?)  (verify)

Laudexium metilsulfate is a neuromuscular blocking drug or skeletal muscle relaxant in the category of non-depolarizing neuromuscular-blocking drugs, used adjunctively in surgical anesthesia to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation.

Laudexium[1] is no longer used in clinical practice, though it was introduced clinically in the early 1950s.[citation needed] It has about half the potency, a slower onset of action and a duration of action much longer than that of d-tubocurarine.[2] As with all clinically established (as well as experimental agents) with a non-depolarizing mechanism of action, its pharmacological action can be antagonized by anticholinesterases.

The displacement of laudexium from clinical use was assured owing to recurrent reports of significant post-operative re-curarization.[3]

References[edit]

  1. ^ Taylor EP (1952). "Synthetic neuromuscular blocking agents. Part II. Bis(quaternary ammonium salts) derived from laudanosine". J Chem Soc: 142–145. doi:10.1039/JR9520000142. 
  2. ^ Hunter AR (1955). "The action of laudexium in man and experimental animals". Br J Anaesth. 27 (2): 73–79. doi:10.1093/bja/27.2.73. PMID 13230365. 
  3. ^ Collier HO, Macauley B (1952). "The pharmacological properties of "laudolissin" a long-acting curarizing agent". Br J Pharmacol Chemother. 7 (3): 398–408. doi:10.1111/j.1476-5381.1952.tb00707.x. PMC 1509112Freely accessible. PMID 12978243. 

External links[edit]